RecruitingNot ApplicableNCT06181929

A Prospective Study for the Early Diagnosis of Lung Cancer in Korean Females

A Prospective Study for the Early Diagnosis of Lung Cancer in Korean Females Who Are Never Smoker with a Family History of Lung Cancer


Sponsor

Sang-Won Um

Enrollment

200 participants

Start Date

Jun 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This is a single-arm prospective pilot study in a single institution. The target accrual is 200 participants of Korean, female sex, never smoker status, and family history of lung cancer. The study will aim to enroll 200 participants in two years.


Eligibility

Sex: FEMALEMin Age: 45 YearsMax Age: 74 Years

Inclusion Criteria4

  • Age 45-74 years old
  • Korean female
  • Never smoker defined as a lifetime exposure of less than 100 cigarettes
  • Family history of lung cancer at first degree relatives (parents, siblings, or children)

Exclusion Criteria6

  • Prior history of lung cancer.
  • Diagnosis of any cancer within the past five years
  • Participation in a cancer prevention trial.
  • Present symptoms suggestive of current lung cancer, including: unexplained weight loss of over 5 kilograms within the last 12 months or unexplained hemoptysis.
  • Medical or psychiatric condition precluding informed medical consent.
  • History of LDCT screening, chest CT, PET or PET/CT scan within 10 years

Interventions

DIAGNOSTIC_TESTLow dose CT

A subject can voluntarily discontinue active screening with LDCTs after the baseline LDCT is completed but will remain in study follow-up with follow-up calls in 12-month intervals for up to 10 years since initial consent


Locations(1)

Samsung Medical Center

Seoul, Seoul, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06181929


Related Trials